Table 4 The proportions of participants using specific types of analgesics or nutraceuticals at baseline according to demographic and clinical characteristics
Variable | Â | n | A'phen | Px NSAID | OTC NSAID | COXIB | Opoids | Gluco/chond | Other nutra |
|---|---|---|---|---|---|---|---|---|---|
Sex | Male | 435 | 8.3% | 6.9% | 25.7% | 6.4% | 1.4% | 42.3% | 9.0% |
| Â | Female | 552 | 17.6% | 9.2% | 27.7% | 13.2% | 4.9% | 39.5% | 8.3% |
Race | White | 701 | 11.6% | 8.0% | 24.7% | 11.7% | 2.7% | 47.4% | 10.1% |
| Â | Non-white | 286 | 18.2% | 8.7% | 32.2% | 6.6% | 4.9% | 24.5% | 4.9% |
Age | <65 | 594 | 12.3% | 10.1% | 27.3% | 9.3% | 3.4% | 40.1% | 8.9% |
| Â | 65 to 74 | 312 | 14.1% | 6.1% | 26.3% | 11.9% | 3.2% | 43.9% | 8.3% |
| Â | >74 | 81 | 19.8% | 2.5% | 25.9% | 11.1% | 3.7% | 33.3% | 7.4% |
KL grade | 2 | 378 | 12.4% | 9.8% | 22.2% | 9.3% | 3.7% | 35.4% | 7.1% |
| Â | 3 | 442 | 13.6% | 7.5% | 30.5% | 9.5% | 3.6% | 39.8% | 7.9% |
| Â | 4 | 167 | 15.6% | 6.6% | 27.5% | 14.4% | 1.8% | 55.1% | 13.8% |
Pain NRS | 0 to 3 | 233 | 6.9% | 6.9% | 19.7% | 9.4% | 0.4% | 47.2% | 7.7% |
| Â | 4 to 7 | 535 | 14.8% | 6.9% | 26.5% | 9.7% | 3.0% | 41.7% | 8.4% |
| Â | 8 to 10 | 219 | 17.4% | 12.8% | 35.2% | 12.3% | 7.3% | 31.5% | 10.0% |
Co-morb | Absent | 696 | 10.1% | 7.6% | 27.2% | 10.6% | 2.7% | 44.8% | 9.9% |
| Â | Present | 291 | 21.6% | 9.6% | 26.1% | 9.3% | 4.8% | 30.9% | 5.5% |
BMI | <26 | 129 | 11.6% | 9.3% | 24.0% | 8.5% | 2.3% | 48.8% | 10.0% |
| Â | 26 to 30 | 381 | 9.7% | 5.0% | 24.9% | 10.0% | 1.6% | 44.9% | 9.7% |
| Â | >30 | 477 | 17.0% | 10.5% | 29.1% | 10.9% | 5.0% | 35.2% | 7.3% |